NextCure, Inc. NXTC
5.08
(0.20)
(3.79%)
as of 25 Sep
- Market cap
- $25.4M
- P/E
- 0.0×
Follow NXTC
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
3.13 | 4.32 | 3.96 | 2.65 | |
Current Ratio |
3.47 | 4.61 | 4.14 | 2.97 | |
Net Debt/EBITDA |
1.35 | 3.01 | 4.43 | 3.44 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.65 | 1.36 | 0.81 | 0.73 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.83) | (2.55) | (2.69) | (2.34) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.83) | (2.55) | (2.69) | (2.34) | |
Cash per Share |
3.78 | 5.68 | 14.71 | 10.88 | |
Shareholders Equity per Share |
2.29 | 5.10 | 12.29 | 8.84 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.29 | 5.10 | 12.29 | 8.84 | |
Free Cash Flow |
(9.71) | (13.36) | (7.64) | (6.27) | |
Working Capital |
15.84 | 24.85 | 33.18 | 21.65 | |
Net Current Asset Value |
11.78 | 20.48 | 28.51 | 16.67 | |
EV/EBIT |
— | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
2.56 | 2.90 | 3.68 | 3.00 | |
Average Assets |
35.15 | 52.56 | 65.52 | 64.98 | |
Average Common Equity |
21.90 | 41.29 | 50.21 | 49.62 |
Columns are period end dates